The global spirometer market size is set to reach US$ 616 million in 2023. Overall sales of spirometer are likely to surge at 5.4% CAGR, taking the forecasted market valuation to US$ 1042.3 million by the end of 2033.
Home-based spirometers have gained popularity in recent years due to the COVID-19 pandemic. With people being more cautious about going to healthcare facilities, home-based spirometers allow patients to monitor their lung health from the comfort of their own homes. This has led to an increased demand for home-based spirometers that are user-friendly, affordable, and accurate.
There is a growing emphasis on patient engagement in healthcare, and spirometers are no exception. Many spirometer manufacturers are developing user-friendly and handheld spirometers with interactive features that engage patients and motivate them to monitor their lung health regularly. For instance, some spirometers come with smartphone apps that allow patients to track their lung function over time and receive reminders to perform
Technological advancements have led to the development of fully electronic spirometers that are easy to use and transport. These spirometers are ideal for people who need to monitor their lung health on the go or outside of clinical settings. Additionally, spirometers that are integrated with electronic medical records (EMR) systems have made it easier for healthcare providers to track patient data and make more informed treatment decisions.
There has been a growing awareness of the importance of preventive healthcare, including the importance of monitoring lung health. As a result, spirometers are being used as a tool for preventive care. For instance, spirometry testing can be used to detect lung function abnormalities before the onset of symptoms, allowing for earlier diagnosis and treatment of respiratory diseases.
| Attributes | Details |
|---|---|
| Spirometer Market CAGR (2023 to 2033) | 5.4% |
| Spirometer Market Size (2023) | US$ 616 million |
| Spirometer Market Size (2033) | US$ 1042.3 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to recent research by Future Market Insights, the spirometer market is projected to expand at a rate of 5.4% during the forecast period from 2023 to 2033. This is a significant growth from the historical growth rate of 2.4%. The market was valued at US$ 532.1 million in 2018, and it is expected to reach US$ 616 million by the end of 2023, and US$ 1042.3 million by 2033. The market outlook could be divided into short-term, medium-term, and long-term.
Short term (2023 to 2025): The demand for home healthcare devices has been on the rise, and spirometers are no exception. Patients and healthcare providers alike are recognizing the benefits of home-based spirometry testing, which can help reduce healthcare costs and improve patient outcomes. As a result, the market for handheld spirometers is expected to grow in the coming years.
Medium-term (2025 to 2028): With the aging population, the demand for spirometers is expected to increase. Older adults are more susceptible to respiratory diseases, and spirometers can help diagnose and monitor these conditions. Additionally, spirometers can be used to detect an age-related decline in lung function, which can help healthcare providers develop treatment plans that can help slow the progression of respiratory diseases.
Long-term (2028 to 2033): Respiratory diseases such as asthma, COPD, and cystic fibrosis are becoming more prevalent globally. This has led to an increased demand for spirometers that can help diagnose and monitor these conditions. Spirometers can be used to measure lung function, which is essential in the diagnosis and treatment of respiratory diseases.
Increase in the prevalence of chronic respiratory diseases: Chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and lung cancer are on the rise globally. This is driving the demand for spirometers, as they are widely used in the diagnosis and management of these conditions.
Growing preference for home healthcare: Patients are increasingly opting for home healthcare services due to the convenience and cost-effectiveness it offers. The development of tele-spirometers has enabled remote monitoring of patients’ respiratory health, which is expected to drive the demand for spirometers in the home healthcare setting.
Technological advancements: Spirometer manufacturers are continuously investing in R&D to develop technologically advanced devices that offer accurate results and are easy to use. The development of portable and wireless spirometers, as well as those that connect to smart devices, has made it easier for clinicians and hospitals to obtain patient data.
Rising geriatric population: The elderly population is predisposed to a range of chronic respiratory disorders, which can be identified through spirometry. The global increase in the geriatric population is therefore expected to drive the demand for spirometers.
Increasing consumer awareness: The growing awareness among consumers about sophisticated diagnostic techniques and their benefits is expected to drive the demand for spirometry.
Principal Consultant
High cost of spirometers: Spirometers can be expensive, especially those that are technologically advanced. This can limit the adoption of these devices in certain regions or by certain demographic groups.
Stringent regulatory requirements: Spirometer manufacturers need to comply with stringent regulatory requirements set by regulatory bodies such as the FDA, which can be time-consuming and expensive.
Lack of awareness and infrastructure: There is a lack of awareness among patients and healthcare professionals about the benefits of spirometry, particularly in developing countries. In addition, the lack of healthcare infrastructure in certain regions can limit the adoption of spirometry.
Interoperability issues: The lack of interoperability between different brands of spirometers can limit the adoption of these devices, particularly in hospitals where multiple brands may be in use.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The United States spirometer market is expected to hold a 20% share of the market in 2023.
There has been a significant shift towards home healthcare in the United States in recent years, which has resulted in increased demand for portable and user-friendly spirometry devices. These devices allow patients to monitor their respiratory conditions at home and reduce the need for frequent visits to medical facilities, driving the growth of the spirometer market.
The United States government has increased funding for respiratory disease research, which has led to the development of new and improved spirometry devices and software. This funding has also led to increased awareness of respiratory diseases and the importance of early detection and management, driving the growth of the spirometer market.
The USA spirometer market is a highly competitive space with several prominent players. Here are some of the top companies in the USA spirometer market:
The Indian spirometer market is expected to grow at a rate of 6.7% throughout the forecast period.
In India, the prevalence of respiratory diseases such as asthma and COPD is high, and the burden of these diseases is expected to increase in the coming years due to factors such as air pollution, smoking, and occupational hazards. This is likely to drive the demand for spirometers in the country. Additionally, the geriatric population in India is increasing, and this population is more susceptible to respiratory diseases, further driving the demand for spirometers.
Advancements in technology are also expected to drive the growth of the Indian spirometer market. For instance, manufacturers are developing spirometers with features such as wireless connectivity, cloud-based data management, and real-time monitoring, which can improve the accuracy and convenience of spirometry testing.
The Japnese spirometer market is expected to hold a share of 5.2% during the forecast period.
Japan is known for its aging population, and with the aging population comes an increased incidence of respiratory illnesses such as COPD, asthma, and lung cancer. These illnesses are commonly associated with a decrease in lung function, and therefore the demand for spirometer devices in Japan is expected to increase in the coming years.
The Chinese Spirometer Market is likely to rise at a rate of 5.3% during the forecast period.
One of the main drivers of the Chinese spirometer market is the country's aging population. Another driver of the market is the increasing incidence of environmental pollution, which has been linked to an increase in respiratory diseases. This has prompted the Chinese government to focus on reducing pollution levels, which is expected to drive demand for spirometry testing and associated equipment.
Top companies in the Chinese market include:
In 2022, COPD had the largest share of the market, at 40.0%. This is because there are a lot of people with mild to severe COPD around the world and spirometry makes it easy to tell if someone has COPD. It was thought that about 7.6% of people in Europe had COPD. Spirometry is a very important part of figuring out if someone has COPD and keeping an eye on them.
But the use of mobile apps like ResAppDx, which can diagnose COPD and COPD symptoms caused by infections, can be an alternative and slow the growth of the segment.
On the other hand, the asthma segment is expected to grow at the fastest rate from 2023 to 2030, with a compound annual growth rate (CAGR) of 10.8%. Every year, asthma costs the NHS about US$1 billion. About 14% of children around the world have asthma and treating asthma in the United States costs more than USD 18 billion each year.
The spirometer market is highly competitive, and the market players have adopted various strategies to gain a larger market share. Here are a few examples:
Beijing Contec Medical Systems Co., Ltd. has adopted a strategy of innovation and product differentiation to gain a competitive advantage in the market. The company invests heavily in research and development to develop new and advanced spirometry devices that offer superior accuracy, reliability, and ease of use. For example, in 2019, Contec launched the CM-6000D spirometer, which is a portable device that offers real-time monitoring and analysis of lung function, making it ideal for use in remote and mobile healthcare settings.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. has adopted a strategy of low-cost leadership to gain a competitive advantage in the market. The company focuses on reducing its production and operating costs to offer its spirometry devices at lower prices than its competitors. For example, Yuyue offers the FVC-2000 spirometer, which is a low-cost, handheld spirometer that is widely used in clinics and hospitals throughout China.
Fukuda Denshi Co., Ltd. has adopted a strategy of international expansion to gain a competitive advantage in the market. The company has established a strong presence in the Chinese market by partnering with local distributors and offering its spirometry devices at competitive prices. Fukuda Denshi also exports its products to other markets, such as Europe, the Americas, and Asia, to diversify its revenue streams and reduce its dependence on any single market.
Schiller AG has adopted a strategy of product innovation and brand building to gain a competitive advantage in the market. The company invests heavily in research and development to develop new and advanced spirometry devices that offer superior accuracy, reliability, and ease of use. Schiller AG also focuses on building its brand and reputation through effective marketing and promotion, such as sponsoring medical conferences and events, to increase its visibility and credibility in the market.
The worldwide spirometer market is expected to be valued at US$ 616 million by the end of 2023.
Beijing Contec Medical Systems Co., Ltd., and Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. , are the key industry players.
The spirometer industry is set to surge at a CAGR of 5.4% from 2023 to 2033.
1. Executive Summary | Spirometer Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033 5.3.1. Hand-Held 5.3.2. Table-Top 5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033 6.3.1. Volume Measurement 6.3.2. Flow Measurement 6.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2023 to 2033 7.3.1. Asthma 7.3.2. COPD 7.3.3. Cystic Fibrosis 7.3.4. Pulmonary Fibrosis 7.4. Y-o-Y Growth Trend Analysis By Application , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-Use 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End-Use, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-Use, 2023 to 2033 8.3.1. Hospitals 8.3.2. Home Healthcare 8.3.3. Clinical Laboratory 8.4. Y-o-Y Growth Trend Analysis By End-Use, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End-Use, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Type 10.2.3. By Technology 10.2.4. By Application 10.2.5. By End-Use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Technology 10.3.4. By Application 10.3.5. By End-Use 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Type 11.2.3. By Technology 11.2.4. By Application 11.2.5. By End-Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Technology 11.3.4. By Application 11.3.5. By End-Use 11.4. Key Takeaways 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UNITED KINGDOM 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Type 12.2.3. By Technology 12.2.4. By Application 12.2.5. By End-Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Technology 12.3.4. By Application 12.3.5. By End-Use 12.4. Key Takeaways 13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Singapore 13.2.1.4. Thailand 13.2.1.5. Rest of South Asia 13.2.2. By Type 13.2.3. By Technology 13.2.4. By Application 13.2.5. By End-Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Technology 13.3.4. By Application 13.3.5. By End-Use 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Type 14.2.3. By Technology 14.2.4. By Application 14.2.5. By End-Use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Technology 14.3.4. By Application 14.3.5. By End-Use 14.4. Key Takeaways 15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Australia 15.2.1.2. New Zealand 15.2.2. By Type 15.2.3. By Technology 15.2.4. By Application 15.2.5. By End-Use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Type 15.3.3. By Technology 15.3.4. By Application 15.3.5. By End-Use 15.4. Key Takeaways 16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Type 16.2.3. By Technology 16.2.4. By Application 16.2.5. By End-Use 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Type 16.3.3. By Technology 16.3.4. By Application 16.3.5. By End-Use 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Type 17.1.2.2. By Technology 17.1.2.3. By Application 17.1.2.4. By End-Use 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Type 17.2.2.2. By Technology 17.2.2.3. By Application 17.2.2.4. By End-Use 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Type 17.3.2.2. By Technology 17.3.2.3. By Application 17.3.2.4. By End-Use 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Type 17.4.2.2. By Technology 17.4.2.3. By Application 17.4.2.4. By End-Use 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Type 17.5.2.2. By Technology 17.5.2.3. By Application 17.5.2.4. By End-Use 17.6. UNITED KINGDOM 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Type 17.6.2.2. By Technology 17.6.2.3. By Application 17.6.2.4. By End-Use 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Type 17.7.2.2. By Technology 17.7.2.3. By Application 17.7.2.4. By End-Use 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Type 17.8.2.2. By Technology 17.8.2.3. By Application 17.8.2.4. By End-Use 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Type 17.9.2.2. By Technology 17.9.2.3. By Application 17.9.2.4. By End-Use 17.10. India 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Type 17.10.2.2. By Technology 17.10.2.3. By Application 17.10.2.4. By End-Use 17.11. Malaysia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Type 17.11.2.2. By Technology 17.11.2.3. By Application 17.11.2.4. By End-Use 17.12. Singapore 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Type 17.12.2.2. By Technology 17.12.2.3. By Application 17.12.2.4. By End-Use 17.13. Thailand 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Type 17.13.2.2. By Technology 17.13.2.3. By Application 17.13.2.4. By End-Use 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Type 17.14.2.2. By Technology 17.14.2.3. By Application 17.14.2.4. By End-Use 17.15. Japan 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Type 17.15.2.2. By Technology 17.15.2.3. By Application 17.15.2.4. By End-Use 17.16. South Korea 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Type 17.16.2.2. By Technology 17.16.2.3. By Application 17.16.2.4. By End-Use 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Type 17.17.2.2. By Technology 17.17.2.3. By Application 17.17.2.4. By End-Use 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Type 17.18.2.2. By Technology 17.18.2.3. By Application 17.18.2.4. By End-Use 17.19. GCC Countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Type 17.19.2.2. By Technology 17.19.2.3. By Application 17.19.2.4. By End-Use 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Type 17.20.2.2. By Technology 17.20.2.3. By Application 17.20.2.4. By End-Use 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Type 17.21.2.2. By Technology 17.21.2.3. By Application 17.21.2.4. By End-Use 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Type 18.3.3. By Technology 18.3.4. By Application 18.3.5. By End-Use 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. nSpire Health Inc. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Vitalograph Ltd. 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Ndd Medical Technologies Inc. 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Medicare Systems Pvt Ltd. 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Welch Allyn Inc. 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Chest M.I. Inc. 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Minato Medical Science Co Ltd. 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Smiths Medical 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Vyaire Medical 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. MGC Diagnostics Corporation 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Testing Equipment Insights
View Reports
Spirometer Market
